Development of a prognostically relevant 'angiogenic signature' in ascites from patients with advanced ovarian cancer

被引：0
|
作者：
Gavalas, N. G. [1 ]
Trachana, S. -P. [1 ]
Pilalis, E. [2 ]
Chatziioannou, A. [2 ]
Papadodima, O. [2 ]
Terpos, E. [1 ]
Dimopoulos, M. A. [1 ]
Bamias, A. [1 ]
机构：
[1] Univ Athens, Sch Med, GR-11527 Athens, Greece
[2] Natl Hellen Res Fdn, Athens, Greece
来源：
IMMUNOLOGY | 2014年 / 143卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
479
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [1] Development of a prognostically relevant "angiogenic signature" in ascites from patients with advanced ovarian cancer
    Trachana, S. P.
    Gavalas, N. G.
    Pilalis, E.
    Papatheodorou, A.
    Chatziioannou, A.
    Papadodima, O.
    Terpos, E.
    Dimopoulos, M. A.
    Bamias, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S716 - S716
  • [2] A prognostically relevant miRNA signature for epithelial ovarian cancer
    Cramer, Daniel W.
    Elias, Kevin M.
    LANCET ONCOLOGY, 2016, 17 (08): : 1032 - 1033
  • [3] The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling
    Trachana, Sofia-Paraskevi
    Pilalis, Eleftherios
    Gavalas, Nikos G.
    Tzannis, Kimon
    Papadodima, Olga
    Liontos, Michalis
    Rodolakis, Alexandros
    Vlachos, Georgios
    Thomakos, Nikolaos
    Haidopoulos, Dimitrios
    Lykka, Maria
    Koutsoukos, Konstantinos
    Kostouros, Efthimios
    Terpos, Evagelos
    Chatziioannou, Aristotelis
    Dimopoulos, Meletios-Athanasios
    Bamias, Aristotelis
    PLOS ONE, 2016, 11 (06):
  • [4] Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer
    Werner, Bonnita
    Powell, Elyse
    Duggan, Jennifer
    Cortesi, Marilisa
    Lee, Yeh Chen
    Arora, Vivek
    Athavale, Ramanand
    Dean, Michael
    Warton, Kristina
    Ford, Caroline E.
    MOLECULAR ONCOLOGY, 2024, 18 (11) : 2668 - 2683
  • [5] Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in a cohort of patients with advanced ovarian cancer
    Werner, Bonnita
    Powell, Elyse
    Duggan, Jennifer
    Lee, Yeh Chen
    Athavale, Ramanand
    Dean, Michael
    Warton, Kristina
    Ford, Caroline
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A32 - A33
  • [6] Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients
    Xu, Y
    Gaudette, DC
    Boynton, JD
    Frankel, A
    Fang, XJ
    Sharma, A
    Hurteau, J
    Casey, G
    Goodbody, A
    Mellors, A
    Holub, BJ
    Mills, GB
    CLINICAL CANCER RESEARCH, 1995, 1 (10) : 1223 - 1232
  • [7] The Angiogenic Activity of Ascites in the Course of Ovarian Cancer as a Marker of Disease Progression
    Gawrychowski, Krzysztof
    Szewczyk, Grzegorz
    Skopinska-Rozewska, Ewa
    Malecki, Maciej
    Barcz, Ewa
    Kaminski, Pawel
    Miedzinska-Maciejewska, Magdalena
    Smiertka, Waclaw
    Szukiewicz, Dariusz
    Skopinski, Piotr
    DISEASE MARKERS, 2014, 2014
  • [8] Cytokine levels in malignant ascites and peripheral blood of patients with advanced ovarian cancer
    Radke, J
    Schmidt, D
    Bohme, M
    Schmidt, U
    Weise, W
    Morenz, J
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1996, 56 (02) : 83 - 87
  • [9] Angiogenic protein expression in advanced epithelial ovarian cancer
    Barton, DPJ
    Cai, A
    Wendt, K
    Young, M
    Gamero, A
    DeCesare, S
    CLINICAL CANCER RESEARCH, 1997, 3 (09) : 1579 - 1586
  • [10] IMPORTANCE OF ASCITES IN OVARIAN CANCER PATIENTS
    Baert, T.
    D'heygere, V.
    Laenen, A.
    Vandecaveye, V.
    Timmerman, D.
    Vergote, I.
    Coosemans, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 629 - 629
12345